Skip to content

Does Timing of VT Ablation Affect Prognosis in Patients With an Implantable Cardioverter-defibrillator?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01547208
Acronym
PARTITA
Enrollment
590
Registered
2012-03-07
Start date
2012-09-30
Completion date
2022-09-30
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Tachycardias

Keywords

ICD shocks, Ventricular tachycardias ablation, Timing of ablation, Electrical storm, Arrhythmic storm

Brief summary

The purpose of this study is to assess whether the burden of untreated non-sustained ventricular tachycardias (VTs), or episodes treated with anti-tachycardia pacing, correlates with appropriate implantable cardiac defibrillator (ICD) shock therapies and to evaluate if the timing of radiofrequency VT ablation affects the prognosis of ICD recipients.

Detailed description

Enrolled patients will remain in a first phase of the study until the first appropriate ICD shock will be delivered. The objective of this first stage is to assess whether the burden of untreated non sustained VTs or episodes treated with anti-tachycardia pacing is predictive of appropriate ICD shocks. The second phase of the study will start after the first appropriate ICD shock delivered for VT. Patients will be then randomized to immediate VT ablation or to standard treatment, meaning waiting until next arrhythmic storm to perform a VT ablation procedure. The objective of this phase is compare the rate of worsening heart failure hospitalizations and deaths from any cause between the two groups.

Interventions

PROCEDUREImmediate radiofrequency ablation of ventricular tachycardia

Radiofrequency ablation of ventricular tachycardia is performed immediately after an appropriate ICD shock

PROCEDURERadiofrequency ablation of ventricular tachycardia

Radiofrequency ablation of ventricular tachycardia will be performed after an arrhythmic storm occurs

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients already implanted with ICD (single-/dual -chamber, with or without cardiac resynchronization therapy) for primary or secondary prevention of sudden cardiac death

Exclusion criteria

Phase A

Design outcomes

Primary

MeasureTime frame
Occurrence of the first appropriate ICD shock during phase AEvent Driven
Number of patients showing worsening heart failure hospitalizations or deaths from any cause during phase BTwo Years

Secondary

MeasureTime frame
Number of patients showing cardiac deaths during phase BTwo Years
Number of patients showing electrical storm (ES) recurrences during phase BTwo Years
Number of patients showing VT recurrences during phase BTwo Years

Countries

Belgium, Czechia, France, Germany, Italy, Portugal, Switzerland

Contacts

Primary ContactAndrea Radinovic
radinovic.andrea@hsr.it
Backup ContactPaolo Della Bella
dellabella.paolo@hsr.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026